|1.||Sun, Shuang-Yong: 2 articles (01/2014 - 01/2013)|
|2.||Deng, Zheng: 2 articles (01/2014 - 01/2013)|
|3.||Zhou, Jun-Jun: 2 articles (01/2014 - 01/2013)|
|4.||Pu, Xiao-Ping: 2 articles (01/2014 - 01/2013)|
|5.||Takahashi, Hitomi: 2 articles (01/2011 - 01/2008)|
|6.||Satake, Masahiro: 2 articles (01/2011 - 01/2008)|
|7.||Shioya, Takanobu: 2 articles (01/2011 - 01/2008)|
|8.||Sato, Kazuhiro: 2 articles (01/2011 - 01/2008)|
|9.||Fujisawa, Takao: 2 articles (01/2011 - 02/2002)|
|10.||Sugawara, Keiyu: 2 articles (01/2011 - 01/2008)|
|1.||Asthma (Bronchial Asthma)
11/01/2008 - "We examined the dose disparity between the bronchodilating effect and anabolic effect of inhaled procaterol, a selective beta (2)-agonist, to determine if the drug might be effective for athletes with asthma. "
10/01/1985 - "Therapeutic efficacy and equivalence of tablet and syrup formulations of procaterol hydrochloride in childhood asthma."
10/01/1985 - "Procaterol, a new beta-2 adrenoceptor stimulant, was studied in a double-blind, placebo-controlled, cross-over trial in patients with bronchial asthma. "
06/01/1985 - "A placebo-controlled trial of procaterol: a new long-acting oral beta 2-agonist in bronchial asthma."
10/01/2010 - "Procaterol is a β2-adrenoceptor agonist used as a bronchodilator for the treatment of asthma; it also possesses an anti-inflammatory property. "
04/01/1992 - "The cough was relieved by inhaled procaterol in 10 patients (Group 2) but not in the other 10 patients (Group 1). "
05/01/2009 - "Procaterol (0.1 mg/kg, intraperitoneal [i.p.]) completely abolished both the Mch-induced increase in Penh and cough. "
12/01/2004 - "Number of coughs, sRaw and total cell number in BALF increased significantly by the OA reinhalation, and the cough number and the increase in sRaw were significantly suppressed by beta2 agonist, procaterol. "
06/01/1993 - "The increment in the cough threshold was not significantly different between the treatments with procaterol and placebo in each group. "
05/01/1989 - "Procaterol (50 micrograms) completely inhibited SP-induced cough in normal subjects with colds. "
06/01/1986 - "Protection against non-specific bronchial hyperreactivity and bronchodilating action of procaterol in atopics."
11/24/1990 - "After 4 weeks with procaterol + 800 micrograms of budesonide, the forced expiratory flow improved (p less than 0.01), the degree of bronchial hyperreactivity to histamine was reduced (p less than 0.001), the daily recorded symptomatology almost disappeared in all and the number of procaterol inhalations was reduced (p less than 0.05). "
|4.||Chest Pain (Chest Pains)
|5.||Chronic Obstructive Pulmonary Disease (COPD)
01/01/2012 - "The aim of this study was to investigate the clinical effect of supplementary inhaled procaterol hydrochloride in patients with COPD. "
01/01/2011 - "In the present study, there was a significant attenuation in exercise dynamic lung hyperinflation, suggesting the important role of the beta2-receptor agonist procaterol in the treatment of COPD. "
07/01/2008 - "The aim of this study was to examine the prolonged effect of procaterol, a short-acting bronchodilator, on lung function and exercise performance in patients with moderate to severe COPD. "
12/01/2012 - "Our data suggest that a pulmonary rehabilitation program combined with inhaled procaterol can improve both HRQOL and exercise tolerance in COPD patients."
12/01/2012 - "Patients with moderate to severe stable COPD were randomly divided into 2 groups those who inhaled procaterol before exercise (n=10) and those who did not (control group) (n=11). "
|3.||Histamine (Histamine Dihydrochloride)
|7.||Bronchodilator Agents (Bronchodilators)
|2.||Metered Dose Inhalers (Metered Dose Inhaler)
|3.||Nebulizers and Vaporizers (Inhaler)
|4.||Dry Powder Inhalers
|5.||Activities of Daily Living (ADL)